PMC:7195088 / 25689-25892 JSONTXT

{"project":"LitCovid-PD-HP","denotations":[{"id":"T27","span":{"begin":74,"end":83},"obj":"Phenotype"}],"attributes":[{"id":"A27","pred":"hp_id","subj":"T27","obj":"http://purl.obolibrary.org/obo/HP_0002090"}],"text":"• Comparison of umifenovir vs. standard of care in patients with COVID-19 pneumonia. Open-label RCT (NCT04260594, not yet recruiting). Primary endpoint: virus negative conversion rate (follow-up 7 days)."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T127","span":{"begin":65,"end":73},"obj":"Disease"},{"id":"T128","span":{"begin":74,"end":83},"obj":"Disease"}],"attributes":[{"id":"A127","pred":"mondo_id","subj":"T127","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A128","pred":"mondo_id","subj":"T128","obj":"http://purl.obolibrary.org/obo/MONDO_0005249"}],"text":"• Comparison of umifenovir vs. standard of care in patients with COVID-19 pneumonia. Open-label RCT (NCT04260594, not yet recruiting). Primary endpoint: virus negative conversion rate (follow-up 7 days)."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T130","span":{"begin":90,"end":95},"obj":"http://purl.obolibrary.org/obo/CLO_0007225"},{"id":"T131","span":{"begin":153,"end":158},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"}],"text":"• Comparison of umifenovir vs. standard of care in patients with COVID-19 pneumonia. Open-label RCT (NCT04260594, not yet recruiting). Primary endpoint: virus negative conversion rate (follow-up 7 days)."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T347","span":{"begin":16,"end":26},"obj":"Chemical"},{"id":"T348","span":{"begin":90,"end":95},"obj":"Chemical"}],"attributes":[{"id":"A347","pred":"chebi_id","subj":"T347","obj":"http://purl.obolibrary.org/obo/CHEBI_134730"},{"id":"A348","pred":"chebi_id","subj":"T348","obj":"http://purl.obolibrary.org/obo/CHEBI_35209"}],"text":"• Comparison of umifenovir vs. standard of care in patients with COVID-19 pneumonia. Open-label RCT (NCT04260594, not yet recruiting). Primary endpoint: virus negative conversion rate (follow-up 7 days)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T191","span":{"begin":85,"end":134},"obj":"Sentence"},{"id":"T192","span":{"begin":135,"end":203},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"• Comparison of umifenovir vs. standard of care in patients with COVID-19 pneumonia. Open-label RCT (NCT04260594, not yet recruiting). Primary endpoint: virus negative conversion rate (follow-up 7 days)."}